Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 10th May 2024 BMRN stock ended at $81.03. This is 0.84% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.50% from a day low at $80.74 to a day high of $81.95.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jun 01, 2016 $88.69 $88.90 $86.01 $87.40 1 285 718
May 31, 2016 $89.35 $91.25 $88.94 $89.65 1 370 934
May 27, 2016 $87.57 $89.22 $86.41 $89.09 846 254
May 26, 2016 $88.04 $88.39 $86.21 $87.26 861 628
May 25, 2016 $88.31 $89.85 $87.50 $88.81 1 062 649
May 24, 2016 $86.32 $88.88 $86.16 $87.95 911 752
May 23, 2016 $86.85 $88.15 $85.35 $85.51 831 160
May 20, 2016 $84.94 $86.63 $84.34 $86.45 869 066
May 19, 2016 $86.46 $87.44 $83.40 $84.75 865 197
May 18, 2016 $83.54 $87.51 $83.21 $87.16 1 186 155
May 17, 2016 $85.73 $87.50 $82.89 $84.05 1 567 254
May 16, 2016 $82.82 $86.80 $82.82 $86.47 1 072 121
May 13, 2016 $79.79 $84.39 $79.79 $82.71 1 359 916
May 12, 2016 $82.51 $83.02 $78.20 $79.79 987 733
May 11, 2016 $87.24 $87.24 $82.09 $82.22 893 941
May 10, 2016 $84.55 $87.62 $82.73 $87.37 1 430 851
May 09, 2016 $81.10 $85.06 $80.57 $83.98 1 035 433
May 06, 2016 $80.36 $82.35 $79.40 $80.80 794 303
May 05, 2016 $82.16 $82.63 $79.32 $80.74 1 073 214
May 04, 2016 $84.15 $84.74 $81.72 $82.14 1 512 358
May 03, 2016 $86.00 $87.41 $84.91 $85.09 1 012 384
May 02, 2016 $85.71 $86.98 $83.92 $86.90 1 112 123
Apr 29, 2016 $83.44 $87.50 $83.02 $84.68 1 704 163
Apr 28, 2016 $86.95 $87.38 $84.60 $85.10 1 472 249
Apr 27, 2016 $88.11 $88.61 $86.22 $87.72 1 010 314
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT